Results 11 to 20 of about 3,791 (140)

Sarcoidosis lung transplantation waitlist mortality, a national registry database study

ERJ Open Research, 2023
Background The Lung Allocation Score (LAS) prioritises lung transplantation candidates, balancing waitlist mortality and post-transplant survival. The score groups sarcoidosis candidates based on mean pulmonary artery pressure: those with ≤30 mmHg ...
Derlis C. Fleitas Sosa, Shameek Gayen, Matthew Zheng, Andrew J. Gangemi, Huaqing Zhao, Victor Kim, Sameep Sehgal, Gerard J. Criner, Rohit Gupta, A. James Mamary   +9 more
doaj   +1 more source

Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study

Respiratory Research, 2022
Background Pirfenidone slows down disease progression in idiopathic pulmonary fibrosis (IPF). Recent studies suggest a treatment effect in progressive pulmonary fibrosis other than IPF.
Jelle R. Miedema, Catharina C. Moor, Marcel Veltkamp, Sara Baart, Natascha S. L. Lie, Jan C. Grutters, Marlies S. Wijsenbeek, Rémy L. M. Mostard   +7 more
doaj   +1 more source

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study

BMC Pulmonary Medicine, 2020
Background Treatment of pulmonary sarcoidosis is recommended in case of significant symptoms, impaired or deteriorating lung function. Evidence-based treatment recommendations are limited and largely based on expert opinion.
Vivienne Kahlmann, Montse Janssen Bonás, Catharina C. Moor, Coline H. M. van Moorsel, Mirjam Kool, Raisa Kraaijvanger, Jan C. Grutters, Mayka Overgaauw, Marcel Veltkamp, Marlies S. Wijsenbeek, Collaborating investigators   +10 more
doaj   +1 more source

The Relationship between Tumor Development and Sarcoidosis in Aspects of Carcinogenesis before and after the Onset of Sarcoidosis

Medicina, 2022
Background and Objectives: It is still unclear whether sarcoidosis is likely to be associated with tumors. In addition, the use of an immune checkpoint inhibitor has been reported to initiate the onset of sarcoidosis.
Yoshimasa Hachisu, Yasuhiko Koga, Shu Kasama, Kyoichi Kaira, Shogo Uno, Masakiyo Yatomi, Haruka Aoki-Saito, Hiroaki Tsurumaki, Asuka Jingu, Noriaki Sunaga, Toshitaka Maeno, Takeshi Hisada   +11 more
doaj   +1 more source

Research progress on drug treament for sarcoidosis [PDF]

Xin yixue, 2023
Sarcoidosis is a systemic disease characterized by non-caseous epithelioid cell granuloma，which can involve with multiple organs，especially the lung. Sarcoidosis is characterized by diverse clinical manifestations and high incidence rate.
Luo Cheng, Wu Cong, Wang Yuguang
doaj   +1 more source

Characteristics and management of ocular sarcoidosis

Immunological Medicine, 2022
Sarcoidosis is a chronic inflammatory disease of unknown etiology that affects many systemic organs, including the eye. The eye is the second most frequently affected organ in patients with sarcoidosis after lung disease. Approximately 30–50% of patients
Hiroshi Takase
doaj   +1 more source

Sarcoidosis and breast cancer: A retrospective case series

Respiratory Medicine Case Reports, 2020
Background: Sarcoidosis and breast cancer co-incidence is reported in the literature in the form of case reports. Aim: To describe our experience from a single large sarcoidosis clinic.
Ilias C. Papanikolaou, Hidenobu Shigemitsu   +1 more
doaj   +1 more source

Sarcoidosis: is there a role for anti-TNF-α?

Revista Portuguesa de Pneumologia, 2007
In severe cases of sarcoidosis treatment can be very difficult. The common treatment strategies might be failing. Tumour necrosis factor (TNF) α therapy is approved in rheumatoid arthritis, M. Crohn, psoriasis and ankylosing spondylitis.
Marjolein Drent
doaj   +1 more source

Environmental Risk Factors for Sarcoidosis

Frontiers in Immunology, 2020
Sarcoidosis is a multisystem granulomatous disease that may affect any body organ. Sarcoidosis is associated with many environmental and occupational exposures. Because the exact immunopathogenesis of sarcoidosis is unknown, it is not known whether these
Marc A. Judson
doaj   +1 more source

Pulmonary miliary sarcoidosis masquerading the reactivation of tuberculosis 30 years later

Clinical Case Reports, 2023
Key Clinical Message Sarcoidosis may occur after treatment with pulmonary tuberculosis and requires differential diagnosis from tuberculosis reactivation.
Takashi Okuma, Reimi Mizushima, Yukihisa Takeda, Kazutoshi Toriyama, Yusuke Watanabe, Hiroyuki Nakamura, Kazutetsu Aoshiba   +6 more
doaj   +1 more source